Wednesday, 11 December 2019

Finance News

  • CX Partners buys major shares in Veeda Clinical Research

    Finance |  News | 0 Comment | 07 Dec, 2018

    A consortium of growth oriented private equity investors led by CX Partners Fund 2 Limited have acquired a significant equity ownership in Veeda Clinical Research Private Limited. The inves...Read more

  • Jubilant Life arm inks pact to acquire Inipharm Inc

    Finance |  News | 0 Comment | 01 Dec, 2018

    Drug firm Jubilant Life Sciences has said that its subsidiary Drug Discovery and Development Solutions Ltd Singapore has entered into an agreement to acquire 10 per cent stake in Inipharm I...Read more

  • Sun Pharma to take over Japan's Polo Pharma

    Finance |  News | 0 Comment | 27 Nov, 2018

    Sun Pharmaceutical Industries Ltd has agreed to buy Japan's Pola Pharma Inc. for $1 million (Rs 7.1 crore). The acquisition is in line with the company's strategy to strengthen its global d...Read more

  • Strides board to invest $15M in Stelis Biopharma

    Finance |  News | 0 Comment | 23 Nov, 2018

    Strides Pharma has announced that the Board of Directors of the Company have approved the participation of Strides in the Series B fundraiser of Stelis Biopharma with a commitment of US$ 15...Read more

  • Aster DM Healthcare reports Q2 net profit at Rs. 11 Crore

    Finance |  News | 0 Comment | 14 Nov, 2018

    Aster DM Healthcare, one of the largest private healthcare service providers in multiple GCC states and an emerging healthcare player in India has announced its financial results for the qu...Read more

  • Sun Pharma Q2 net loss at Rs 219 cr

    Finance |  News | 0 Comment | 14 Nov, 2018

    Drug major Sun Pharmaceutical Industries has reported a consolidated net loss of Rs 218.82 crore for the July-September quarter on account of a Rs 1,214-crore provision for the settlement o...Read more

  • Glenmark Pharmaceuticals Q2 net profit jumps 93.3%

    Finance |  News | 0 Comment | 14 Nov, 2018

    Glenmark Pharmaceuticals has reported a 93.3 per cent jump in consolidated net profit at Rs 4.14 billion for the quarter ending September boosted by the sale of its orthopaedic and pain man...Read more

  • Kilitch Drugs (India) records a robust growth in Q2FY19

    Finance |  News | 0 Comment | 13 Nov, 2018

    The Board of Directors of Kilitch Drugs India Limited announced its un-audited results for the second quarter ended on September 30, 2018 following its approval by the Board of Directors in...Read more

  • Natco Pharma posts over two-fold jump in Q2 PAT to Rs 181.6 Cr

    Finance |  News | 0 Comment | 06 Nov, 2018

    Natco Pharma has reported over two-fold increase in consolidated profit after tax at Rs 181.6 crore for the second quarter ended September 30, 2018. The company had posted a consolidated p...Read more

  • Unichem picks up stakes in Optimus Group

    Finance |  News | 0 Comment | 05 Nov, 2018

    Unichem Laboratories has acquired 19.99% each in two bulk drug companies of Hyderabad-based pharmaceutical group Optimus for a total of Rs 120 crore ($16.5 million). As part of the transac...Read more

  • Cipla announces Q2 FY19 results

    Finance |  News | 0 Comment | 05 Nov, 2018

    Cipla Limited has announced its unaudited consolidated financial results for quarter ended September 30, 2018. Key highlights of the quarter are: R&D investments at approximately IN...Read more

  • Torrent Pharma reports 12.25% dip in its Q2 net profit

    Finance |  News | 0 Comment | 05 Nov, 2018

    Drug firm Torrent Pharmaceuticals has reported a 12.25 per cent dip in its consolidated net profit to Rs 179 crore for the quarter ended September 2018 due to one-time impact of a product r...Read more

  • Strides Pharma to get $20M from ICP

    Finance |  News | 0 Comment | 01 Nov, 2018

    Strides Pharma Science Ltd said its board has approved ICP-III Investment Advisors infusing $20 million growth capital into its two consumer healthcare business arms, the company ...Read more

  • Lupin Q2 net profit drops 41.5 pc to Rs 266 cr

    Finance |  News | 0 Comment | 01 Nov, 2018

    Drug maker Lupin has reported a 41.5 per cent decline in its consolidated net profit at Rs 266 crore for the second quarter ended September 30, 2018 as sales slipped in the US market. The M...Read more

  • Columbia Asia sells Ahmedabad unit to Zydus

    Finance |  News | 0 Comment | 01 Nov, 2018

    Columbia Asia Hospitals Pvt. Ltd has sold one of its dozen hospitals in India to Zydus Hospitals for an undisclosed amount. According to Columbia Asia, it has sold its only hospital in Ahm...Read more

  • Granules India’s Net Profit grew by 49% to Rs 60 Cr.

    Finance |  News | 0 Comment | 30 Oct, 2018

    Granules India Ltd., a growing pharmaceutical manufacturing company has announced its financial results for the second quarter ended 30th September 2018. The company reported total income ...Read more

  • Divi's Labs Q2 profit surges by 92%

    Finance |  News | 0 Comment | 29 Oct, 2018

    Divi's Laboratories, a Rs.3,800 crore plus manufacturer of active pharmaceutical ingredients and intermediates major from Hyderabad, has registered impressive top line and bottom line ...Read more

  • Pharma sector growth to moderate at 7-9% CAGR for FY 2018-21

    Finance |  News | 0 Comment | 23 Oct, 2018

    The growth trajectory for the Indian pharmaceutical industry is likely to be moderate at 7-9% over FY2018 to FY2021, on the back of healthy demand from the domestic market given increasing ...Read more